Numinus CEO Speaks On Australia’s Precedent-Setting Decision To Allow Psychedelic Assisted Therapy Feb 8, 2023
Awakn’s Dr. Ben Sessa: Ketamine Assisted Therapy Providing “Breakthrough, Transformative Experience” Jan 31, 2023
Pelorus Equity Group Co-Founding President Talks Macro Cannabis And The Mistakes Of Equity Investing Jan 15, 2023
Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
Numinus In Strong Position To Capture US$2.5 Billion Psychedelic-Assisted Therapy Market Dec 20, 2022
